Psychopharmacology - Articles - Page 7

Tips for Good Medication Practice

June 28, 2019

The following are some recommendations on good medication practice from child psychiatrist Mark Chenven, MD, who offered his expertise in The Carlat Child Psychiatry Report:Start low, go slow: Most side effects are dose related, so gradual up-titration is simple common sense. This allows for the body’s homeostatic and regulatory mechanisms...

Medications for Depression

June 11, 2019

Martha J. Ignaszewski, MD

Martha J. Ignaszewski, MD

Chief Fellow, Clinical Fellow in Psychiatry at Boston Children’s Hospital

Dr. Ignaszewski has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In this QA, we review the findings of placebo- controlled trials done over the past 10 years on depression in kids and the discuss the current recommendations for medication treatment of depression in children and adolescents.

Using Clozapine Effectively, Safely

June 5, 2019

According to most treatment guidelines, you should consider clozapine after inadequate response to at least two antipsychotics. For patients who are extremely aggressive or suicidal, the APA treatment guidelines state that a trial of clozapine may be reasonable as a first or second line antipsychotic. Here are some additional tips...

Medication treatment for ADHD

March 28, 2019

Choosing and prescribing the right medications for treating ADHD can be challenging. The Carlat Child Psychiatry Report spoke with Anne Buchanan, DO, Child psychiatrist at Maimonides Medical Center in Brooklyn, NY, about her approach. She offers the following tips.When choosing meds, Dr. Buchanan recommends that you: Consider stimulants first line.

Evaluating the Mortality Risks of Antipsychotics in Children and Youths

March 13, 2019

There are reports of increased mortality from antipsychotics in older adults. Now, we have a paper showing increased mortality in children, adolescents, and young adults aged 5–24 years. Given the frequent use, both on- and off-label, of antipsychotics, does this change how we use them? And if so, how?

Prescription CBD Is Available, But Are We Ready to Use It?

January 1, 2019

Chris Aiken, MD

Chris Aiken, MD Editor-in-Chief of The Carlat Psychiatry Report. Practicing psychiatrist, Winston-Salem, NC. Dr. Aiken has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Your patient comes in with a new medication on his list: CBD oil. He started taking it for anxiety and wants to know if it’s safe. You hedge, explaining that there is limited information available on unregulated products, but the patient is persistent. He says CBD oil is available as a prescription, and wonders if you could write one for it.

Deprescribing Medication

January 1, 2019

Barbara Farrell, PharmD

Barbara Farrell, PharmD

Assistant Professor, Department of Family Medicine, University of Ottawa and Adjunct Assistant Professor, School of Pharmacy, University of Waterloo. Co-founder of the Canadian Deprescribing Network. Dr. Farrell has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Deprescribing refers to lowering or stopping medications that might be causing harm or no longer providing benefit. It’s done in a planned, collaborative, and supervised way rather than simply the patient stopping the medications independently.

Quick Take Video - ADHD in Children and Adolescents

November 12, 2018

Editor-in-Chief of The Carlat Child Psychiatry Report, Dr. Joshua D. Feder, discusses the latest issue about ADHD in children and adolescents. The issue features an expert interview with Mark Katz, MD.https://youtu.be/BKJW647gggUBecome a subscriber here.

EXPERT Q&A

Effects of Drug Interactions

November 1, 2018

Neil Sandson, MD

Neil Sandson, MD.
Clinical Associate Professor, Department of Psychiatry at University of Maryland School of Medicine

Dr. Sandson has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

When it comes to computer alerts for drug interactions, the two issues to pay attention to are toxicity and loss of efficacy. Toxicity is the bigger concern, particularly if the drug has a “narrow therapeutic index,” where modest differences in the level can have dangerous effects.

Ask the Editor: Three Significant Food Interactions with ADHD Medications

October 1, 2018

Chris Aiken, MD.

Chris Aiken, MD.

Editor -in-Chief of The Carlat Psychiatry Report. Practicing psychiatrist, Winston-Salem, NC. Dr. Aiken has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Patients often ask how their stimulant medication interacts with food. Can you tell us more about this?